B Lymphocyte Development
THE IMMUNE SYSTEM
Development of B Lymphocytes
Chapter Overview
Chapter focuses on the development of B lymphocytes (B cells) in the immune system.
Describes key processes, checkpoints, genetic rearrangements, and interactions within the bone marrow and secondary lymphoid tissues.
6-1 B-cell Development in the Bone Marrow
B-cell development proceeds through several stages: - Originates from pluripotent hematopoietic stem cells. - Development is influenced by bone marrow stromal cells.
negative selection happens at bone marrow
Bone marrow: essentially blood, mesenchymal cells that traveled into bone
Figures: - 6.1: Phases of B-cell development, highlighting that negative selection begins in the bone marrow and continues in secondary lymphoid organs. - 6.2: Illustrates the migration of B cells from the bone marrow to secondary lymphoid tissues for maturation.
At every stage, many cells are prevented from entering the next phase
Body only expands and diminishes the clones according to circumstances as we make them every day as well as loose them
B-cells start development in bone marrow, circulates into blood stream and become mature in secondary lymphoid organ where they will be waiting to be activated.
Different stages can be marked by different surface proteins present
Stages of B cell development > immature B cell
Mostly rearranging their heavy and light chain arrangements in the DNA of their immunoglobulin genes, with some checkpoints
6-2 Influence of Bone Marrow Stromal Cells
Key Points: - Bone Marrow Stromal Cells are essential for the development of B cells. - These cells provide necessary signals and physical contacts. - The dependence on stromal cell contact diminishes in later stages of B-cell development.
Bone marrow stromal cell stimulation relases IL-7, which will stimulate pro B cells to further develop
Stromal cell stimulation also contributes to prouction of necessary recombination enzymes such as repair enzymes etc. (heavy and light chain rearrangements in B cell)
Figures: - 6.5: Early stages of B-cell development show dependence on stromal cells.
6-3 Rearrangement of Immunoglobulin Heavy-Chain Genes in Pro-B Cells
In pro-B cells, the rearrangement of heavy-chain genes is critical: - Results in both productive and nonproductive rearrangements. - Default pathway is apoptosis unless survival signals are received.
Key Factors: - Important transcription factors (E2A, EBF, Pax-5) regulate somatic recombination involved in heavy-chain rearrangement.
Figures: - 6.6: Representation of gene rearrangements in pro-B cells.
6-4 Pre-B-cell Receptor Function
The pre-B-cell receptor (pre-BCR) serves crucial functions: - Monitors the quality of immunoglobulin heavy chains. - Signals the cell to cease heavy-chain rearrangement and to switch to light-chain rearrangement. - Induces allelic exclusion ensuring production of homogeneous B-cell receptors. - A lack of this exclusion results in heterogeneous receptors with reduced avidity.
Figures: - 6.7: Diagram showing the pre-BCR and its role in directing B-cell development.
6-5 Rearrangement of Light-Chain Loci in Pre-B Cells
Light-chain rearrangement occurs in pre-B cells and follows successful heavy-chain expression. - Increases chances of producing functional immunoglobulin. - The presence of functional surface immunoglobulin IgM inhibits further light-chain rearrangements.
Figures: - 6.8: Organization of light-chain loci showing rearrangement processes.
6-6 Checkpoints in B-cell Development
B cells face critical checkpoints during development: - First checkpoint: assesses productive rearrangement of heavy-chain genes ( pre- beta cell receptor.) - Second checkpoint: ensures light-chain genes rearrangements have resulted in functional receptors ( B-cell receptor). - Cells that fail at these checkpoints undergo apoptosis.
Figures: - 6.10: Flowchart of the rearrangement and selection process in B-cell development.
6-7 Protein Expression in B-cell Development
Timing and expression of proteins are crucial to B-cell development stages. - Varying proteins influence immunoglobulin gene rearrangements and B-cell maturation.
Figures: - 6.11: Development timeline of immunoglobulin-related proteins.
Different proteins expressed at different points orchestrtate development of functional B cells.
6-8 Tumors and Chromosomal Translocations
Many B-cell tumors exhibit chromosomal translocations leading to Ig genes joining with genes that regulate cell growth, leading to malignancies: - E.g., Burkitt’s lymphoma associated with translocations that alter cell growth regulation. - Distinction between proto-oncogenes (normal growth-regulating genes) and oncogenes (cancer-promoting genes).
Figures: - 6.13: Illustrates chromosomal rearrangements in B-cell tumors.
6-9 Distinction of CD5+ and CD5- B cells
CD5+ B cells (often B-1 cells) differ from typical B-2 cells: - Produced mainly in the fetal stage, have limited receptor diversity, and a unique anatomical distribution (peritoneal and pleural cavities). - No T-cell help required for activation, low somatic hypermutation rate, etc.
Figures: - 6.14: Comparison chart between B-1 and B-2 cells.
Selection and Further Development of B-cell Repertoire
6-10 Purging of Self-Reactive B-cell Receptors
Immature B cells that recognize self-reactive receptors are eliminated during development in the bone marrow: » - Critical for establishing tolerance and preventing autoimmunity.
Figures: - 6.16: Process showing how multivalent self antigens activate self-reactive B cells.
6-11 Receptor Editing of Autoreactive B Cells
Receptor editing allows immature B cells to modify their receptors if they initially interact with multivalent self-antigens: - Light-chain rearrangement allows self-reactive receptors to adapt. - Failure to produce a non-self-reactive receptor results in apoptosis.
Chance to modify their receptors so they can not recognize self.
Figures: - 6.17: Illustration of receptor editing mechanics in self-reactive B cells.
6-12 Non-responsiveness to Monovalent Self Antigens
Immature B cells that encounter monovalent self antigens typically become nonresponsive (anergic): - Characterized by reduced surface IgM and shorter half-life, aiming to limit potential autoimmunity.
Figures: - 6.18: Graphical representation of B cells undergoing anergy.
6-13 Maturation in Lymphoid Follicles
After immature B cells exit the bone marrow, they mature in lymphoid follicles: - This phase is essential for generating diverse and clonally expressed receptors.
**Phases of Maturation: ** - Phase 1: Generation of diverse B-cell receptors in the bone marrow. - Phase 2: Negative selection of self-reactive receptors. - Phase 3: Positive selection to promote maturation. - Phase 4: Recirculation for infection searching. - Phase 5: Activation by specific antigens and clonal expansion. - Phase 6: Differentiation into plasma cells and memory B cells.
Figures: - 6.19: Routes of B-cell circulation in tissues.
go to lymphoid follical to get stimulated and matured
6-14 Activation and Differentiation Upon Antigen Encounter
Antigen exposure leads to activated B cells differentiating into plasma cells and memory B cells: - Plasma cells secrete IgM and stop proliferating, while memory B cells participate in later immune responses.
Figures: - 6.21: Workflow of B-cell activation and differentiation.
6-15 Diversity in B-cell Tumors
The variety in B-cell tumors correlates with differentiation stages of B cells, reflecting the complexity of their development: - Understanding this diversity helps in tailoring therapeutic strategies.
Figures: - 6.22: Summary of the relationship between tumor diversity and B-cell development.
Summary of Key Concepts
The development of B lymphocytes incorporates stages of cellular development, genetic rearrangements, checkpoints, and interactions with stromal cells.
Various pathways and decisions made during development play crucial roles in B-cell functionality, tolerance, and malignancy potential in certain contexts.
B cells undergo rigorous selection processes to ensure autoreactive cells are eliminated or rendered inactive, culminating in a highly specialized immune response upon activation.